MMP2 as an independent prognostic stratifier in oral cavity cancers

BACKGROUND: Around 25% of oral cavity squamous cell carcinoma (OCSCC) are not controlled by the standard of care, but there is currently no validated biomarker to identify those patients. Our objective was to determine a robust biomarker for severe OCSCC, using a biology-driven strategy. PATIENTS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Caroline, Vacher, Sophie, Sirven, Philémon, Lecerf, Charlotte, Massenet, Lucile, Moreira, Aurélie, Surun, Aurore, Schnitzler, Anne, Klijanienko, Jerzy, Mariani, Odette, Jeannot, Emmanuelle, Badois, Nathalie, Lesnik, Maria, Choussy, Olivier, Le Tourneau, Christophe, Guillot-Delost, Maude, Kamal, Maud, Bieche, Ivan, Soumelis, Vassili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466851/
https://www.ncbi.nlm.nih.gov/pubmed/32934875
http://dx.doi.org/10.1080/2162402X.2020.1754094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466851/
https://www.ncbi.nlm.nih.gov/pubmed/32934875
http://dx.doi.org/10.1080/2162402X.2020.1754094

Ejemplares similares